Logo
  • Home
  • Diagnosis
    • Create New
    • Dashboard
  • Documentation
    Login Register

Disclaimer

This dysferlinopathy progression prediction tool is a research tool only and is intended for research and educational purposes. The results provided by this tool MUST NOT be used as a clinical diagnosis or for making clinical decisions without proper interpretation by a qualified healthcare professional.

This tool has been designed to work with data from ambulant patients. Non-ambulant patients were excluded from the model and, as such, results may be incorrect for non-ambulat patients. Please, avoid using this tool for non-ambulant patients.

The predictions are based on statistical models and should be interpreted in the context of the individual patient's complete clinical picture. The tool is under continuous development and improvements may be made periodically.

If you encounter any issues or have suggestions, please contact us at [email protected].

The tool is provided "as is", without warranty of any kind, express or implied. In no event shall the authors or copyright holders be liable for any claim, damages or other liability arising from, out of or in connection with the tool or the use or other dealings in the tool.

Dysferlinopathy stage of progression prediction tool

This page contains the prediction model presented in the paper "Identification of prognostic biomarkers in a large cohort of patients with LGMD R2", currently under review. This page is intended for reviewers, if you gained access to this URL we highly advise you to ignore this page until the paper has been peer-reviewed and published. Documentation for the tool will be added on publication.

This tool has been designed to work with data from ambulant patients. Non-ambulant patients were excluded from the model and, as such, results may be incorrect for non-ambulat patients. Please, avoid using this tool for non-ambulant patients.

If you use this tool as part of your research, please cite the following paper:

Reference (under review)
Identification of prognostic biomarkers in a large cohort of patients with LGMD R2

Bolano-Diaz C, Verdu-Diaz J, James MK, Hilsden H, ..., Jain COS Consortium, Volker S, Diaz-Manera J

To be published, DOI: https://doi.org/placeholder

  • With MRI
  • Without MRI
Model 1 - With MRI

Enter the following MRI and clinical variables:

Years since disease onset
Enter percentage value (0-100)
Enter area in cm²
Enter percentage value (0-100)
Enter area in cm²
Prediction Result

Prediction: --

Prediction Visualization
Prediction visualization
Model 2 - Without MRI

Enter the following clinical variables:

Years since disease onset
Enter CK
10 meter walk/run velocity in meters per second
Prediction Result

Prediction: --

Prediction Visualization
Prediction visualization
Copyright © Myo-Guide 2026